Empty bladder may steady the target in rectal cancer radiation
NCT ID NCT04323722
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether having an empty bladder reduces movement of the mesorectum (tissue around the rectum) during radiotherapy for rectal cancer. About 50 adults with rectal cancer receive planning CT scans and weekly CBCT scans under both empty and full bladder conditions. The goal is to see if bladder depletion leads to more stable positioning, which could improve treatment accuracy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If confirmed, emptying the bladder before radiotherapy could make treatment more precise, potentially reducing side effects for rectal cancer patients.
- What could go wrong
- This is a small observational study, not a treatment trial. Results may not lead to changes in practice, and individual anatomy varies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICO René Gauducheau
Saint-Herblain, 44805, France
-
Institut de Cacerologie de l'ouest - site Paul Papin
Angers, 49055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet and vitamin c supercharge rectal cancer treatment?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Which rectal cancer surgery preserves quality of life better? a study investigates
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- Can AI learn to grade endoscopy quality from video?
- Can precision protons spare rectal cancer patients from harsh side effects?